All Articles Tagged With: "Prostate Cancer"
Articles
Avodart, Propecia, Proscar Prostate Cancer Warning Issued in Canada
Canadian health officials are warning that side effects of Propecia, Proscar and Avodart may increase the risk of developing high-grade prostate cancer, following similar warnings issued last year in the United States.
Medtronic Infuse Bone Graft Cancer Concerns Raised by New Study
Medtronic’s Infuse bone graft product could be linked to an increased risk of cancer, according to the findings of a new study.
Prostate Cancer Risk May Be Increased by Vitamin E Supplements: Study
Vitamin E supplements may be linked to an increase in the risk of prostate cancer among men, U.S. researchers say.
Prostate Cancer Risk from Avodart, Proscar Lead to Warning Against Use
The prominent consumer watchdog group Public Citizen is warning men not to use Avodart, Proscar or similar drugs for the treatment of enlarged prostate, due to the potential increased risk of prostate cancer.
Merck Redesigns Drug Label for Zocor, Propecia, Januvia, Other Drugs
Federal regulators have signed off on a redesign for the labels of a number of Merck drugs, including Zocor, Propecia, Januvia and a dozen other drugs, to improve readability and reduce the risk of medication mistakes and prescription errors.
Propecia, Avodart Prostate Cancer Warning Issued by FDA
Side effects of Propecia, Avodart and similar drugs could raise the risk of prostate cancer, U.S. health officials warned this week.
Deadly Infections Linked to Prostate Exams: Reports
The findings of several recent studies suggest that prostate exams may carry an increased risk of antibiotic resistant infections, which have sometimes proven to be deadly.
Trelstar and MixJect System Warning: Recalled Alcohol Pads Included in Kits
Watson Pharmaceuticals, Inc. is the latest drug maker to announce that one of its medications was shipped with recalled alcohol pads, which may be contaminated and pose a risk of serious and potentially life-threatening infections.
One-A-Day Vitamin Lawsuits Settled for $3.3M
Bayer has reached a $3.3 million settlement with three states who sued the company over marketing claims that it’s One A Day Men’s multivitamins reduced the chances of developing prostate cancer.
FDA Adds Heart Disease Risk, Diabetes Warning to Prostate Cancer Drugs
Federal drug regulators are calling for new heart disease and diabetes warnings to be added to a class of prostate cancer drugs that includes Eligard, Lupron, Synarel, Trelstar, Vantas, Viadur, and Zoladex.
